
John Singer
Articles
-
Nov 7, 2024 |
quadrant.org.au | Daryl McCann |Thomas Mayo |Timothy Cootes |John Singer
Despite the Voice's overwhelming rejection, the likes of Thomas Mayo and our cultural elites carry on as if never happenedNov 07 20248 minsHow did Robert Kennedy Jr come to team up with Donald Trump? It starts with free speechNov 07 202416 minsMore certain than the sun coming up tomorrow was leftoid journalists' whimpering about Dictator Donald's victoryNov 06 202419 minsDuring the campaign for the Voice to Parliament, the most effective get-out-the-no-vote strategy came from an unlikely source.
-
Oct 15, 2024 |
quadrant.org.au | Dyson Heydon |John Singer |Tony Thomas |Nicholas Hasluck
'No' voters didn't reject Aboriginal advancement. Rather, they vetoed the sort of 'advancement' Yes backers had in mindOct 15 202411 minsWere those who pushed the Voice genuinely serious, the Aboriginal Industry would be the first thing to be addressed. Oct 14 20244 minsThe ABC's claims of Trump's 'falsehoods' turn out to be falsehoods themselves. But correct the record?
-
Oct 14, 2024 |
quadrant.org.au | Christopher Akehurst |John Singer |Tony Thomas |Roger Franklin
Were those who pushed the Voice genuinely serious, the Aboriginal Industry would be the first thing to be addressed. Oct 14 20244 minsThe ABC's claims of Trump's 'falsehoods' turn out to be falsehoods themselves. But correct the record? No wayOct 14 202418 minsKamala has a new ad aimed at keeping men in the Democrat fold. A kick in the testicles would have been just as well receivedOct 14 20247 minsSome criticism of ABCTV is wordless.
-
Oct 14, 2024 |
quadrant.org.au | John Singer
-
Feb 28, 2024 |
pharmaboardroom.com | John Singer
Lex is the flagship investment column of the Financial Times. Its commentaries, currently written by a team of eleven investment writers in five times zones, has been published daily in the newspaper since 1945. “We believe it is the most influential column of its kind” in the world, says the paper. Early in February, the commentary was about market strategy in the pharmaceutical industry: ‘Big Pharma still needs trial success to overcome looming patent panic’:“It is a tale as old as time.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →